Launch of the CE-IVD-Marked HIV-1 Treatment-Resistant Strain Assay by Thermo Fisher Scientific


Hitesh

Thermo Fisher Scientific, a global leader in providing scientific services, today announced the release of its CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay that analyses HIV-positive samples to find genetic variants that may resist conventional antiretroviral therapies. The test’s results can be used to […]

ShiftMed Announces Technology Partnership with UKG to Further Streamline Scheduling and Drive Down Operational Costs for Healthcare Facilities


Hitesh

In order to further streamline scheduling and reduce operational costs for healthcare facilities, ShiftMed and UKG have announced a technology partnership ShiftMed, the first on-demand workforce platform that offers scalable, affordable, and sustainable labour across the full spectrum of care settings—from health system acute and outpatient settings to post-acute and […]

Bioarctic’s Partner Eisai Submits Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer’s Disease In Japan 


Hitesh

A marketing authorization application for lecanemab, an investigational anti-amyloid beta (A) protofibril antibody, has been submitted by BioArctic AB’s (publ) partner Eisai to the Pharmaceuticals and Medical Devices Agency for the treatment of mild cognitive impairment (MCI) brought on by Alzheimer’s disease (AD) and mild Alzheimer’s dementia (collectively known as […]

Autolomous aims to provide digital solutions to Centers for Breakthrough Medicines to streamline and automate cell and gene therapy manufacturing


Hitesh

The US Center for Breakthrough Medicines (CBM), a Cell and Gene Therapy Contract Organization for Development, Manufacturing, and Testing, has entered into a licencing agreement with Autolomous LTD, the market-leading developer of critical manufacturing management systems for cell and gene therapies (CGT) (CDMO). With the help of the agreement, Autolomous […]